This paper is in the following e-collection/theme issue:

Cross-Sectional Studies in Public Health (453) Vaccination and Immunization in the Digital Age (450) Infectious Diseases (non-STD/STI) (1738) Outbreak and Pandemic Preparedness and Management (1839) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1544) Breast Cancer (303) Rapid Surveillance Report (13)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46009, first published .
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China

Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China

Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China

Authors of this article:

Shaohua Zhang1 Author Orcid Image ;   Jianbin Li1, 2 Author Orcid Image ;   Ruonan Xu1 Author Orcid Image ;   Qianjun Chen3 Author Orcid Image ;   Gang Sun4 Author Orcid Image ;   Ying Lin5 Author Orcid Image ;   Yali Cao6 Author Orcid Image ;   Yiding Chen7 Author Orcid Image ;   Cuizhi Geng8 Author Orcid Image ;   Yuee Teng9 Author Orcid Image ;   Jianyun Nie10 Author Orcid Image ;   Xinzheng Li11 Author Orcid Image ;   Guiying Xu12 Author Orcid Image ;   Xinlan Liu13 Author Orcid Image ;   Feng Jin9 Author Orcid Image ;   Zhimin Fan14 Author Orcid Image ;   Ting Luo15 Author Orcid Image ;   Hong Liu16 Author Orcid Image ;   Fu-sheng Wang1 Author Orcid Image ;   Zefei Jiang1 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Shueng P, Ting W, Chang C, Chang W, Tseng Y, Chang C, Chen G. Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients. Discover Oncology 2026 View